QA: ACHILLION PHARMACEUTICALS INC in us_pharma/2016

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001070336_2017_ACHILLION_PHARMACEUTICALS_INC.pdf

Logs

warning Missing logo subcommand.report {}
info Failed to set obs_EconomicCapitalRatio industry.us_generic {'reason': "KeyError('0001070336')"}

Graph

Absolute values for 0001070336, ACHILLION PHARMACEUTICALS INC

  xvar xval
0 AssetsCurrent 382,535,000
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 3,479,000
3 remainder_Assets 27,861,000
4 LiabilitiesCurrent 13,971,000
5 LiabilitiesNoncurrent 301,000
6 remainder_Liabilities 149,000
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 20,703,000
9 ResearchAndDevelopmentExpense 59,162,000
10 remainder_Expenses 68,000
11 remainder_Revenues 15,000,000
12 remainder_NetIncome 3,227,000
13 remainder_ComprehensiveNetIncome 196,000
  yvar yval
0 Assets 413,875,000
1 Liabilities 14,421,000
2 Expenses 79,933,000
3 Revenues 15,000,000
4 StockholdersEquity 399,454,000
5 NetIncome -61,706,000
6 ComprehensiveNetIncome -61,608,000
7 BaseVar 263,326,000
8 EconomicCapitalRatio 2.92

Edgar->Model Mapping

Feature Distribution